FFM2 - Mini I Flashcards
Pharmacology
Study of substances that will interact with living systems via chemical processes
Drug
Molecule that will bind to target to exert effect
Prototype drug
First form of a drug/medication
Is used to formulate alternative forms
Pharmacokinetics
What body does to drug
Pharmacodynamics
What drug does to body
Toxicology
Science of adverse effects of chemicals on body
Pharmacogenetics
Relationship between persons genetic makeup and response to specific drugs
What is main item that NBME tests on for medication names?
Generic names of medications
Mechanism of action
How drug works to produce change in body
Pharmacologic drug action
Consequences of drug-receptor combination
Pharmacologic effect
Results of drug action
Consequences of drugs own actions
Precaution
Used when medication use should be used with care and careful monitoring of patient
Contraindication
Specific circumstance where medication should NOT be used
Relative Contraindication
Caution needs to be used when 2 meds used together
Benefits outweigh risks
Absolute contraindication
Substance can cause life-threatening and should be avoided
Black box warning
Serious/life threatening risks associated with
Most serious medication warning from FDA
Therapeutic effect
Beneficial consequence of treatment
Adverse event
Harmful/abnormal result form medication
Pregnancy Risk Catagories
A
B
C
D
X
Which pregnancy risk catagories are adverse?
C
D
X
Affinity
Strength of interaction between drug and target
Potency
Amount of drug necessary to produce effect
EC50
Concentration drug needed to produce 50% of max effect
Efficacy
Largest effect achieved with drug, regardless of dosage
Agonist
Bind to receptor
Produce normal response
Antagonist
Bind to receptor
Compete and prevent binding by other molecules
Will block actions OF agonist
Full Agonist
Complete 100% activation of receptor
Partial agonist
Binding to receptor results in >0% but < 100% of activation even with high concentrations
Inverse agonist
Bind to receptor and will produce a response BELOW baseline response
Decreased concentration of drug
Competitive antagonist
Bind to same site
Lowers efficacy of medication
Decreases EC50 of medication
Noncompetitive anatgonist
Bind covalently to receptor
Permanent reduction of # of receptors
Irreversible
EC50 remains same; efficacy decreases
Selectivity
Degree to which drug acts on given site relative to other sites
Nonselective drug
Affects many different tissues producing range of effects
Selective drug
Affects single organ/system
Local effects of medication
Application to site of action
Systemic effects
Drug enters circulation and transported to cellular site of action
Routes of Administration:
Enteral
Oral, sublingual/buccal, rectal
Routes of Administration:
Paraenteral
IV/IA
IM
SubQ
Intradermal
Routes of Administration:
Other types
Oral inhalation
Intrathecal/intraventricular
Topical
Transdermal
Vaginal
Urethral
Absorption
Entering blood stream from site of administration
Distribution
Process which drug reversibly leave bloodstream and enters ECF and tissues
Metabolism
Biochemical changes to medication to facilitate elimination from body
Elimination
Irreversible removal of medication from body
Renal most common
Bioavailability
Extent to which medication reaches systemic circulation
Factors affecting Absorption
ph changes
Blood low
Presence/absence of transporters
First pass effect (Liver/GI metabolism)
Drug formulation
Factors affecting Distribution
CO and Blood flow
Permeability of capillaries
Degree of binding of drug to proteins in blood/tissue
Lipophilicity of medication
MW
Central compartment of body
Highly perfused organs
Heart/Liver/Kidneys
Peripheral compartment of body
Fat tissues
Muscle tissues
CSF
Instantaneous distribution within body
One-compartment
All fluids/tissues considered part of compartment
Delayed distribution within body
Some areas get medication faster than others…
Two-compartments
Distribution into high vascular organs then everywhere else more slowly
Metabolism of meds in 3 ways
1)
2)
3)
1) Active med to inactive med
2) Active med to active metabolite
3) Inactive med to active med
Volume of Distribution (Vd)
Fluid volume required to contain entire drug in body at same concentration as measured in plasma
Equation for Vd
Dose of drug/drug concentration
Factors affecting Vd
Drug MW
Lipophilic or hydrophilic
Ionization at pH
Protein binding
Disease states
Half Life (T1/2)
Time it takes to reduce plasma concentration by 1/2
Clearance (CL)
Volume of blood from which drug is cleared per unit of time